SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001223
Filing Date
2023-05-15
Accepted
2023-05-15 16:15:46
Documents
49
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgrx-20230331x10q.htm   iXBRL 10-Q 819958
2 EX-31.1 rgrx-20230331xex31d1.htm EX-31.1 15399
3 EX-32.1 rgrx-20230331xex32d1.htm EX-32.1 9826
  Complete submission text file 0001410578-23-001223.txt   3519498

Data Files

Seq Description Document Type Size
4 EX-101.SCH rgrx-20230331.xsd EX-101.SCH 31072
5 EX-101.CAL rgrx-20230331_cal.xml EX-101.CAL 26446
6 EX-101.DEF rgrx-20230331_def.xml EX-101.DEF 89301
7 EX-101.LAB rgrx-20230331_lab.xml EX-101.LAB 231253
8 EX-101.PRE rgrx-20230331_pre.xml EX-101.PRE 187778
43 EXTRACTED XBRL INSTANCE DOCUMENT rgrx-20230331x10q_htm.xml XML 452376
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 23922561
SIC: 2834 Pharmaceutical Preparations